In short
This article discusses a clinical trial investigating the use of Niflumic Acid, a non-steroidal anti-inflammatory drug (NSAID), as part of a walking rehabilitation program for patients with hip or knee osteoarthritis. The study aims to evaluate the effectiveness and tolerance of this treatment approach in improving patients' mobility and quality of life.
At a glance
- Study Title
- Patient Walking Rehabilitation Program with osteoarthritis of the hip or knee helped by a one-off anti-inflammatory treatment (PERIPATEI)
- Main Objective
- Study the efficacy and tolerance of NSAID intake in a walking rehabilitation program for hip or knee osteoarthritis patients
- Participant Age Range
- 50 to 70 years old
- Key Inclusion Criteria
- Idiopathic osteoarthritis of hip or knee, walking pain rated at least 4/10, limited walking ability
- Main Exclusion Criteria
- Pregnancy, certain medical conditions, hypersensitivity to NSAIDs, severe organ dysfunction
- Primary Endpoint
- 30% increase in monthly target movements without NSAID discontinuation due to intolerance
- Drug Studied
- Niflumic Acid (NIFLURIL 250 mg, capsule)
- Maximum Daily Dose
- 500 mg
- Administration Route
- Oral
What is Niflumic Acid?
Niflumic Acid is a medication that belongs to a class of drugs called non-steroidal anti-inflammatory drugs (NSAIDs). It is primarily used to treat pain and inflammation associated with various conditions, including osteoarthritis. In France, it is marketed under the brand name NIFLURIL 250 mg, in the form of a capsule (gélule in French).
Medical Uses
Niflumic Acid is primarily used in the treatment of:
- Osteoarthritis: A degenerative joint disease that causes pain and stiffness in joints, particularly in the hip and knee.
- Other inflammatory conditions: While not specifically mentioned in the provided clinical trial data, NSAIDs like Niflumic Acid are often used to treat various inflammatory conditions.
Dosage and Administration
According to the information provided:
- The maximum daily dose of Niflumic Acid is 500 mg.
- The maximum total dose over the course of treatment is 300 g.
- The medication is taken orally, typically in capsule form.
- The maximum treatment period mentioned is 12 weeks.
It's important to note that these are maximum doses and treatment durations. Your doctor will prescribe the appropriate dosage for your specific condition and circumstances.
Potential Benefits
While the clinical trial data doesn't provide specific information about the benefits of Niflumic Acid, NSAIDs like this medication are generally used to:
- Reduce pain associated with osteoarthritis
- Decrease inflammation in affected joints
- Improve mobility and quality of life for patients with osteoarthritis
Precautions and Contraindications
Based on the information provided in the clinical trial data, there are several precautions and contraindications to consider when using NSAIDs like Niflumic Acid. While these are not specific to Niflumic Acid, they apply to the class of drugs it belongs to:
- Allergic reactions: Patients with a history of hypersensitivity reactions to NSAIDs or aspirin should avoid this medication.
- Gastrointestinal issues: Those with a history of gastrointestinal bleeding, perforation, or active peptic ulcers should use caution.
- Liver and kidney function: Patients with severe liver or kidney problems may not be suitable candidates for this medication.
- Cardiovascular health: People with uncontrolled high blood pressure or congestive heart failure should consult their doctor before using this medication.
- Pregnancy and breastfeeding: Pregnant or breastfeeding women should avoid this medication.
Ongoing Research
A clinical trial named PERIPATEI is currently studying the use of NSAIDs, including Niflumic Acid, as part of a walking rehabilitation program for patients with hip or knee osteoarthritis. The study aims to:
- Evaluate the effectiveness and tolerance of NSAIDs in improving walking ability for osteoarthritis patients.
- Assess patient compliance with the program and identify factors that contribute to its success.
- Investigate the impact of central sensitization (a condition where the nervous system becomes overly sensitive to pain) on the effectiveness of NSAID treatment.
This research may provide valuable insights into the optimal use of Niflumic Acid and other NSAIDs in the management of osteoarthritis, particularly in conjunction with exercise programs.